Definitive Healthcare Corp.

Technology
Computer Software: Prepackaged Software
www.definitivehc.com

Moat Score
Safety Score

Market Cap $547.58M
PE -1
Debt $246.42M
Cash $137.61M
EV $656.39M
FCF $52.73M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$520.09M
EBIT	-$555.32M
ROE	-75%
ROA	-47%
FCF	$52.73M
Equity	$695.56M
Growth Stability	1
PE	-1.05
PB	0.79
P/FCF	10.38
P/S	2.14
Price/Cash	0.25
Debt/Equity	0.35
Debt/FCF	4.67
Net Margins	-267%
Gross Margins	79%
Op. Margins	-217%
Sales Growth YoY	-4%
Sales Growth QoQ	-2%
Sales CAGR	27%
FCF CAGR	19%
Equity CAGR	11%
Earnings Growth YoY	-24%
Earnings Growth QoQ	-39%

Sales CAGR 5Y	27%
FCF CAGR 5Y	21%
Equity CAGR 5Y	-3%
Earnings CAGR 3Y	17%
Sales CAGR 3Y	17%
FCF CAGR 3Y	31%
Equity CAGR 3Y	-21%
Market Cap	$547.58M
Revenue	$255.85M
Assets	$1.18B
Total Debt	$246.42M
Cash	$137.61M
Shares Outstanding	116.38M
EV	656.39M
Moat Score	1%
Safety Score	87%
Working Capital	220.5M
Current Ratio	2.49
Gross Profit	$203.29M
Shares Growth 3y	10%
Equity Growth QoQ	-22%
Equity Growth YoY	-42%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of revenue from the United States.

SEC Filings

Direct access to Definitive Healthcare Corp. (DH) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Definitive Healthcare Corp. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Definitive Healthcare Corp. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Definitive Healthcare Corp. Discounted Cash Flow

Fully customizable DCF calculator online for Definitive Healthcare Corp..

Years

Calculation mode

= $2B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$53M	$63M	$75M	$89M	$106M	$126M	$151M	$179M	$214M	$255M	$303M	$3B
DCF		$57M	$62M	$67M	$73M	$79M	$85M	$92M	$100M	$108M	$117M	$1.2B
Value	$2B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	-43%	-37%	-10%	-115%	-267%
ROA	-1%	-1%	-2%	-17%	-47%
ROE	-4%	-4%	-1%	-24%	-75%

Bad Net Margins (-266.82%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	21.88	15.16	10.09	7.11	4.67
Debt over Equity	0.4	0.19	0.18	0.23	0.35
Growth Stability	-	-	-	-	1

Bad Debt/FCF ratio (4.67)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Good Debt/Equity ratio (0.35)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	40%	34%	13%	27%
Earnings YoY growth	-	20%	-64%	1K%	-
Equity YoY growth	-	26%	-1%	-19%	-3%
FCF YoY growth	-	-15%	47%	40%	21%